Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it

**Revolutionizing Medicine with AI: Abridge's Ambitious Clinician Intelligence Platform**

Imagine a world where medical professionals can effortlessly document patient-clinician conversations, receive real-time clinical decision support, and generate accurate billing codes and patient summaries, all while maintaining a seamless and patient-centered experience. This is the vision behind Abridge, a pioneering startup that has just announced a groundbreaking strategic investment from pharma giant Eli Lilly, alongside a partnership with NVIDIA to develop the first AI-native clinician intelligence platform.

Background & Context

Abridge was founded in 2018 by Dr. Shiv Rao, a seasoned healthcare expert with a passion for harnessing the potential of ambient AI to transform the medical industry. Over the years, the company has garnered significant attention for its innovative approach to documenting and analyzing patient-clinician conversations. Today, Abridge's platform is live in over 300 health systems, supporting more than 100 million clinical conversations annually and serving over 250 million patients.

The healthcare industry is on the cusp of a revolution, driven by the rapid advancement of artificial intelligence and machine learning technologies. As healthcare systems grapple with the complexities of providing high-quality care to an increasingly diverse and aging population, the need for efficient, patient-centered solutions has never been more pressing. Abridge's ambitious platform is poised to play a significant role in shaping the future of healthcare, by connecting the dots across the main stakeholders in the industry and driving business model innovation.

Key Details

At the heart of Abridge's platform lies a sophisticated AI model that can capture conversation between patients and doctors in real-time, automatically generating clinical notes, billing codes, and patient summaries. This cutting-edge technology has been trained on the specific dynamics of doctor-patient dialogue, allowing it to provide relevant clinical guidelines and care gaps without requiring the physician to switch applications. The platform also surfaces discussion topics and relevant clinical guidelines during the encounter, streamlining the clinician's workflow and enhancing the overall patient experience.

Abridge's partnership with NVIDIA is a significant milestone in the company's journey, as it marks the first time a foundation model for clinical conversations has been co-developed with a leading AI technology provider. This collaboration has the potential to unlock new levels of efficiency and accuracy in clinical decision support, billing, and patient documentation. Additionally, Abridge's integration with Artisight, a smart hospital company backed by NVIDIA, will provide care teams with a continuous feed of room sensor data and ambient documentation across an entire hospital stay.

What Experts Say

Dr. Rao's vision for Abridge's platform is centered around the idea that AI can be a powerful tool for driving business model innovation in healthcare. "If we can't actually improve how healthcare is delivered, how it's experienced, and how it's paid for, then we haven't really moved the needle on the problem," he emphasizes. This sentiment is echoed by experts in the field, who recognize the potential of Abridge's platform to transform the healthcare industry. "Abridge's clinician intelligence platform is a game-changer for healthcare, offering a holistic solution that addresses the needs of patients, clinicians, and payers alike," says a leading healthcare expert.

Key Takeaways

• Abridge's AI-native clinician intelligence platform is poised to revolutionize the healthcare industry, offering a seamless and patient-centered experience for clinicians and patients alike.
• The platform's sophisticated AI model can capture conversation between patients and doctors in real-time, generating clinical notes, billing codes, and patient summaries with unprecedented accuracy.
• Abridge's partnership with NVIDIA marks a significant milestone in the development of foundation models for clinical conversations, unlocking new levels of efficiency and accuracy in clinical decision support, billing, and patient documentation.
• The integration of Abridge's platform with Artisight will provide care teams with a continuous feed of room sensor data and ambient documentation across an entire hospital stay, enhancing the overall patient experience and streamlining clinical workflows.

What This Means For You

As a patient or healthcare professional, the implications of Abridge's platform are profound. With the ability to document and analyze patient-clinician conversations in real-time, clinicians can provide more personalized and effective care, while patients can enjoy a more seamless and patient-centered experience. Furthermore, the platform's potential to drive business model innovation in healthcare has the potential to transform the industry as a whole, making high-quality care more accessible and affordable for all.

As we move forward in this rapidly evolving healthcare landscape, it is essential that we prioritize innovation, collaboration, and patient-centered care. Abridge's clinician intelligence platform is a shining example of what can be achieved when we harness the power of AI and machine learning to drive meaningful change in the industry. By embracing this vision and working together, we can create a brighter future for healthcare that benefits patients, clinicians, and payers alike.